期刊文献+

缺血修饰性白蛋白在ACS和AIS患者中的诊断价值 被引量:2

Diagnostic value of ischemia-modified albumin in acute coronary syndrome and acute ischemic stroke
下载PDF
导出
摘要 目的:探讨外周血缺血修饰性白蛋白(ischemia-modified albumin,IMA)水平在急性冠脉综合征(acute coronary syn-drome,ACS)和急性缺血性脑卒中( acute ischemic stroke,AIS)中的诊断价值。方法:收集2013年9月~2014年11月皖南医学院附属弋矶山医院急诊科收治的ACS和AIS患者及健康体检者全血标本,分为ACS组、AIS组和对照组,每组收集满50例为止。检测血清中IMA浓度。结果:IMA在ACS组和AIS组患者中的水平分别为(88.3±10.2) U/mL和(92.6±10.4) U/mL,显著高于对照组(71.6±9.8)U/mL(P<0.001)。 ACS组和AIS组患者中IMA的水平与肌钙蛋白Ⅰ(Trop Ⅰ)水平间的关联无统计学差异(两组均为P>0.05)。 IMA灵敏度在ACS组和AIS组中分别为86%和88%,特异性分别为92%和94%。结论:由诊断界值确定的灵敏度和特异度表明,IMA是ACS患者和AIS患者诊断的有益指标。 Objective:To assess the diagnostic value by measuring the level of serum ischemia modified albumin ( IMA) in early diagnosis of patients with acute myocardial ischemia(ACS) and acute ischemic stroke(AIS).Methods:The whole blood samples were collected from the ACS and AIS patients(n=50) admitted to the Emergency Department of our hospital between September 2013 and November 2014,and health subjects(n=50).Then the partici-pants were allocated to ACS group,AIS group and control group,and serum IMA levels were measure.Results:The serum IMA concentration was (88.3 ± 10.2)U/mL and (92.6 ±10.4)U/mL for ACS and AIS patients,which was higher than the healthy controls(71.6 ±9.8) U/mL,P〈0.001.IMA level and troponin I level were not significant between ACS patients and AIS patients(P〉0.05),and IMA sensitivity and specificity were 86% and 92% in ACS group compared to 88% and 94% in AIS group.Conclusion:The serum IMA level may be a useful indicator in diagnosis of patients with acute myo-cardial ischemia and acute ischemic stroke.
出处 《皖南医学院学报》 CAS 2015年第4期329-332,共4页 Journal of Wannan Medical College
基金 皖南医学院附属弋矶山医院三新项目(Y1360) 安徽省质量工程(大学生创新训练项目)(AH201410368144)
关键词 局部缺血 缺血修饰性白蛋白 急性冠脉综合征 急性脑卒中 ischemia ischemia modified albumin acute coronary syndrome acute ischemic stroke
  • 相关文献

参考文献12

  • 1柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量:2149
  • 2Jauch EC,Cucchiara B,Adeoye O,et al.Part 11:Adult Stroke:2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care[J].Circulation,2010,122:818-828.
  • 3Laskowitz DT,Kasner SE,Saver J,et al.BRAIN Study Group.Clinical usefulness of a biomarker-based diagnostic test for acute stroke:the Biomarker Rapid Assessment in Ischemic Injury(BRAIN)study[J].Stroke,2009,40(1):77-85.
  • 4Apple FS,Wu AH,Mair J,et al.Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome[J].Clin Chem,2005,51:810-824.
  • 5Anwaruddin S,Januzzi JL,Baggish AL,et al.Ischemia-modified albumin improves the usefulness of standard cardiac biomarkers for the diagnosis of myocardial ischemia in the emergency department setting[J].Am J Clin Pathol,2005,123(1):140-145.
  • 6Liyan C,Jie Z,Yonghua W,et al.Assay of ischemia-modified albumin and C-reactive protein for early diagnosis of acute coronary syndromes[J].J Clin Lab Anal,2008,22(1):45-49.
  • 7Chawla R,Goyal N,Calton R,et al.Ischemia modified albumin:a novel marker for acute coronary syndrome[J].Ind J Clin Biochem,2006,21(1):77-82.
  • 8Ozdem S,Cete Y,Donmez L,et al.Serum levels of ischemia-modified albumin(IMA)in healthy adults and patients with acute coronary syndrome[J].Tr J Emerg Med,2005,5(4):169-174.
  • 9Sinha MK,Roy D,Gaze DC,et al.Role of“Ischemia modified albumin”,a new biochemical marker of myocardial ischaemia,in the early diagnosis of acute coronary syndromes[J].Emerg Med J,2004,21(1):29-34.
  • 10Zini I,Tomasi A,Grimaldi R,et al.Detection of free radicals during brain ischemia and reperfusion by spin trapping and microdialysis[J].Neurosci Lett,1992,138(2):279-282.

二级参考文献24

  • 1李小鹰.阿司匹林在动脉硬化性心血管疾病中的临床应用:中国专家共识(2005)[J].中华心血管病杂志,2006,34(3):281-284. 被引量:194
  • 2Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines(Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol,2002, 40(7) :1366-1374.
  • 3Bertrand ME, Simoons ML, Fox KA, et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J,2002,23 ( 23 ) : 1809 -1840.
  • 4Erhardt L, Herlitz J, Bossaert L, et al. Task force on the management of chest pain. Eur Heart J, 2002, 23 ( 15 ) : 1153-1176.
  • 5CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet, 1996, 348(9038) :1329-1339.
  • 6Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med, 2001 , 345 ( 7 ) :494-502.
  • 7Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet, 2001, 358(9281):527-533.
  • 8Simoons ML, GUSTO IV-ACS Investigators. Effect of glycopmtein Ⅱb/Ⅲa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation:the GUSTO IV-ACS randomised trial. Lancet, 2001,357(9272) :1915-1924.
  • 9Platlat Receptor Inhibitor in Ischemic Syndrome Management(PRISM) study investigator. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. Platelet Receptor Inhibition in Ischemic Syndrome Management ( PRISM )Study Investigators. N Engl J Med, 1998, 338(21 ) :1498-1505.
  • 10Platlat Receptor Inhibitor in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms(PRISM-PLUS) study investigator. Inhibition of the platelet giycoprotein Ⅱb/Ⅲa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators. N Engl J Med,1998, 338(21) :1488-1497.

共引文献2148

同被引文献19

引证文献2

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部